About Diversigen
Diversigen is a Healthcare company based in Houston (United States) founded in 2013, and was acquired by OraSure in November 2019. Metagenomic services for the health, agriculture, and oil and gas industries. Its focus areas include Life Sciences, Genomics, Genomics Services and Full Service. Its competitors include Trace Genomics, Kallyope and AnimalBiome; 3 of its 3 listed competitors have raised funding.
Company details
Diversigen was founded in 2013 in Houston, United States, where metagenomic services are delivered to health, agriculture, and oil and gas industries. Offerings include 16S rRNA gene sequencing, 18S rRNA gene sequencing, whole genome shotgun sequencing, single organism genome sequencing, transcriptome sequencing, and viral metagenomic sequencing. These support applications in drug discovery, clinical research, diagnostics, crop protection, plant performance regulation, and oil and gas productivity enhancements.
- Headquarters Houston, United States
- Stage Acquired
- SectorsHealthcare
- Website diversigen.com
- Social LinkedIn X
- Acquired by OraSure (Nov 2019)
- Investors
- Acquired byOraSure
(Nov 2019)
Investors in Diversigen
Diversigen has secured backing from 1 investor. Prominent investors backing the company include OraSure Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Point-of-care diagnostic devices for oral fluid specimens are provided. | 1987 | orasure.com | Bethlehem, United States |
Investor details for Diversigen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Diversigen
9 people are tracked at Diversigen (1 in leadership, 4 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Kathleen Weber | President, Diversigen & President, Molecular Solutions | Leadership |
Dan Knights | Advisor | Board & advisors |
Daryl Gohl | Advisor | Board & advisors |
Kenny Beckman | Advisor | Board & advisors |
Eric Pamer | Advisor | Board & advisors |
Priyanka Narendar | Business Development Manager | Team |
Brittany Guerrero | Inside Business Development Specialist | Team |
Michael V. | Sr. Lab Operations Manager | Team |
Craig Byer | Operations Specialist | Team |
Complete people profiles for Diversigen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Diversigen
2 dated milestones of Diversigen across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Diversigen is founded.
- Exit Acquired by OraSure.
Competitors of Diversigen
Diversigen has 3 listed competitors in our database, 3 of them funded. They include Trace Genomics, Kallyope and AnimalBiome.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tracegenomics.com | 2015 | San Francisco, United States | $53.62M | 51 | Developer of technologies to diagnose soil health and soil-borne disease prediction | |
| kallyope.com | 2014 | New York, United States | $479M | 84 | The gut-brain axis is explored for therapeutic and nutritional innovations. | |
| animalbiome.com | 2016 | San Francisco, United States | $25.88M | 52 | Animal microbiome diagnostics services for pet care are offered. |
Detailed competitors of Diversigen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Diversigen
The website of Diversigen (diversigen.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▲ 0.8% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Diversigen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Diversigen
Complete news archive for Diversigen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diversigen
Diversigen was founded in 2013.
Diversigen is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Diversigen was founded in 2013 in Houston, United States, where metagenomic services are delivered to health, agriculture, and oil and gas industries. Offerings include 16S rRNA gene sequencing, 18S rRNA gene sequencing, whole genome shotgun sequencing, single organism genome sequencing, transcriptome sequencing, and viral metagenomic sequencing. These support applications in drug discovery, clinical research, diagnostics, crop protection, plant performance regulation, and oil and gas productivity enhancements.
Diversigen's top competitors include Trace Genomics, Kallyope and AnimalBiome.
Diversigen has 1 investor. Key investors include OraSure Technologies.
Yes. Diversigen was acquired by OraSure in November 2019.